NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002440

Registered date:01/10/2009

The effect of Ezetimibe in hypercholesterolemic patients with Nonaicoholic fatty liver disease(NAFLD)

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedNonaicoholic fatty liver disease
Date of first enrollment2008/01/01
Target sample size50
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Ezetimibe

Outcome(s)

Primary Outcome1) Histological and immunohistochemical analysis of analysis of liver 2) L/S ratio by CT 3) Various biological markers of liver didease.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1.patients being taken Ezetimibe 2.patients with serious liver disease 3.secondary hyperlipidemia or drug-induced hyperlipidemia 4.pregnant or lactating women 5.aicoholconsumption>21g/day

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail parkh50@hotmail.com
Affiliation Saiseikai Suita Hospital Internal medicine
scientific contact
Name Takeshi Okanoue
Address 1-2 Kawazonocho, Suita, 564-0013, Japan Japan
Telephone
E-mail
Affiliation Saiseikai Suita Hospital Gastroenterology and Hepatology